MapLight Therapeutics, Inc. · NASDAQ:MPLT

MapLight Therapeutics, Inc. financial statements

MapLight Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022
Revenue0
Cost of revenue578.0K701.0K556.0K574.0K
Gross profit-578.0K-701.0K-556.0K-574.0K
Research and development138.3M68.5M49.1M26.6M
Selling, general and administrative30.7M14.4M7.61M4.10M
Operating income-169.1M-82.9M-57.3M-31.2M
Depreciation and amortization578.0K701.0K556.0K574.0K
EBITDA-168.5M-82.2M-56.7M-30.7M
Income before tax-161.2M-77.6M-55.7M-30.0M
Net income-161.2M-77.6M-55.7M-30.0M
Earnings per share, basic-18.56-105.38-1.34-0.72
Earnings per share, diluted-18.56-105.38

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents46.7M38.3M79.8M27.7M
Short-term investments258.4M70.5M
Current assets324.7M114.6M83.6M32.0M
Property, plant and equipment1.09M1.21M
Total assets479.5M136.9M91.4M39.4M
Accounts payable3.29M1.91M3.25M3.60M
Current liabilities16.2M15.9M14.7M12.6M
Total debt5.80M6.58M5.92M6.27M
Total liabilities21.1M21.7M20.1M18.5M
Shareholders' equity458.4M-193.6M71.3M20.9M
Shares outstanding44.0M761.3K41.4M41.4M

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-138.1M-78.8M-52.0M-26.6M
Capital spending-473.0K-770.0K-462.0K-746.0K
Free cash flow-138.6M-79.6M-52.5M-27.3M
Cash from investing-323.2M-80.8M-462.0K-746.0K
Cash from financing469.8M118.1M104.6M33.2M
Change in cash8.48M-41.5M52.1M27.7M